Your browser doesn't support javascript.
loading
Opportunities and challenges of hepatocellular carcinoma organoids for targeted drugs sensitivity screening.
Xie, Cuiying; Gu, Ancheng; Khan, Muhammad; Yao, Xiangcao; Chen, Leping; He, Jiali; Yuan, Fumiao; Wang, Ping; Yang, Yufan; Wei, Yerong; Tang, Fang; Su, Hualong; Chen, Jiamin; Li, Jinxia; Cen, Bohong; Xu, Zhongyuan.
Afiliación
  • Xie C; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Gu A; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Khan M; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yao X; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Chen L; Department of Radiation Oncology, Affiliated Cancer Hospital and Institute of Guangzhou Medical University, Guangzhou, Guangdong, China.
  • He J; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yuan F; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Wang P; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Yang Y; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Wei Y; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Tang F; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Su H; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Chen J; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Li J; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
  • Cen B; National Medical Products Administration (NMPA) Key Laboratory for Research and Evaluation of Drug Metabolism and Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, China.
  • Xu Z; Clinical Pharmacy Center, Nanfang Hospital, Southern Medical University, Guangzhou, China.
Front Oncol ; 12: 1105454, 2022.
Article en En | MEDLINE | ID: mdl-36686807
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Diagnostic_studies / Screening_studies Idioma: En Revista: Front Oncol Año: 2022 Tipo del documento: Article País de afiliación: China Pais de publicación: Suiza